Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 23021687)

1.

Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis.

Gallos ID, Yap J, Rajkhowa M, Luesley DM, Coomarasamy A, Gupta JK.

Am J Obstet Gynecol. 2012 Oct;207(4):266.e1-12. doi: 10.1016/j.ajog.2012.08.011. Epub 2012 Aug 10. Review.

PMID:
23021687
2.

[Fertility sparing management of endometrial adenocarcinoma and atypical hyperplasia: a literature review].

Koskas M, Yazbeck C, Walker F, Delorme P, Azria E, Luton D, Madelenat P.

Bull Cancer. 2012 Jan;99(1):51-60. doi: 10.1684/bdc.2011.1516. Review. French.

PMID:
22212645
3.

Impact of obesity on the results of fertility-sparing management for atypical hyperplasia and grade 1 endometrial cancer.

Gonthier C, Walker F, Luton D, Yazbeck C, Madelenat P, Koskas M.

Gynecol Oncol. 2014 Apr;133(1):33-7. doi: 10.1016/j.ygyno.2013.11.007.

PMID:
24680589
4.

Conservative management of young patients with endometrial highly-differentiated adenocarcinoma.

Kalogiannidis I, Agorastos T.

J Obstet Gynaecol. 2011;31(1):13-7. doi: 10.3109/01443615.2010.532249. Review.

PMID:
21280986
6.

[Pregnant rate and pregnancy-relating factors of patients with early endometrial carcinoma and severe atypical hyperplasia of endometrium after fertility-preserving treatment by progestin].

Cao DY, Yu M, Yang JX, Shen K, Huang HF, Cheng NH, Sun ZY, Deng CY, Yu Q, He FF.

Zhonghua Fu Chan Ke Za Zhi. 2013 Jul;48(7):519-22. Chinese.

PMID:
24284224
7.

Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin.

Simpson AN, Feigenberg T, Clarke BA, Gien LT, Ismiil N, Laframboise S, Massey C, Ferguson SE.

Gynecol Oncol. 2014 May;133(2):229-33. doi: 10.1016/j.ygyno.2014.02.020. Epub 2014 Feb 19.

PMID:
24561246
8.

Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review.

Gunderson CC, Fader AN, Carson KA, Bristow RE.

Gynecol Oncol. 2012 May;125(2):477-82. doi: 10.1016/j.ygyno.2012.01.003. Epub 2012 Jan 11. Review.

PMID:
22245711
9.

Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic review and meta-analysis.

Koskas M, Uzan J, Luton D, Rouzier R, Daraï E.

Fertil Steril. 2014 Mar;101(3):785-94. doi: 10.1016/j.fertnstert.2013.11.028. Epub 2014 Jan 2. Review.

PMID:
24388202
10.

The influence of infertility treatment on the prognosis of endometrial cancer and atypical complex endometrial hyperplasia.

Ichinose M, Fujimoto A, Osuga Y, Minaguchi T, Kawana K, Yano T, Kozuma S.

Int J Gynecol Cancer. 2013 Feb;23(2):288-93. doi: 10.1097/IGC.0b013e31827c18a1.

PMID:
23314282
11.

Pregnancy outcomes using assisted reproductive technology after fertility-preserving therapy in patients with endometrial adenocarcinoma or atypical complex hyperplasia.

Han AR, Kwon YS, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH.

Int J Gynecol Cancer. 2009 Jan;19(1):147-51. doi: 10.1111/IGC.0b013e31819960ba.

PMID:
19258957
12.

Fertility-sparing therapy in young women with endometrial cancer: 2010 update.

Erkanli S, Ayhan A.

Int J Gynecol Cancer. 2010 Oct;20(7):1170-87. Review.

PMID:
21495221
13.
14.

Reproductive and oncologic outcomes after progestin therapy for endometrial complex atypical hyperplasia or carcinoma.

Kudesia R, Singer T, Caputo TA, Holcomb KM, Kligman I, Rosenwaks Z, Gupta D.

Am J Obstet Gynecol. 2014 Mar;210(3):255.e1-4. doi: 10.1016/j.ajog.2013.11.001. Epub 2013 Nov 8.

PMID:
24211482
15.

Progression of conservatively treated endometrial complex atypical hyperplasia in a young woman: a case report.

Corrado G, Baiocco E, Carosi M, Vizza E.

Fertil Steril. 2008 Nov;90(5):2006.e5-8. doi: 10.1016/j.fertnstert.2008.06.014. Epub 2008 Aug 9.

PMID:
18692828
16.

Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome.

Kaku T, Yoshikawa H, Tsuda H, Sakamoto A, Fukunaga M, Kuwabara Y, Hataeg M, Kodama S, Kuzuya K, Sato S, Nishimura T, Hiura M, Nakano H, Iwasaka T, Miyazaki K, Kamura T.

Cancer Lett. 2001 Jun 10;167(1):39-48.

PMID:
11323097
17.

Successful pregnancies in 2 infertile patients with endometrial adenocarcinoma.

Nakao Y, Nomiyama M, Kojima K, Matsumoto Y, Yamasaki F, Iwasaka T.

Gynecol Obstet Invest. 2004;58(2):68-71. Epub 2004 Apr 20.

PMID:
15103232
18.
19.

Fertility-sparing treatment of endometrial cancer precursors among young women: a reproductive point of view.

Ricciardi E, Maniglio P, Frega A, Marci R, Caserta D, Moscarini M.

Eur Rev Med Pharmacol Sci. 2012 Dec;16(14):1934-7.

20.

Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy.

De Marzi P, Bergamini A, Luchini S, Petrone M, Taccagni GL, Mangili G, Colombo G, Candiani M.

J Minim Invasive Gynecol. 2015 Jun 16. pii: S1553-4650(15)00490-2. doi: 10.1016/j.jmig.2015.06.004. [Epub ahead of print]

PMID:
26092080
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk